ALZHEIMER DISEASE & ASSOCIATED DISORDERS : Impact Factor & More

eISSN: 0893-0341pISSN: 0893-0341

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS Key Metrics

Impact Factor
< 5
SJR
Q2Gerontology
Time to Publish
time-to-publish View Chart
7
 Mo
Time to Publish

Sign up now and unlock a detailed chart of Time to publish for this journal

% of papers by time taken from submission to publication
0 to 3 months
0%
4 to 6 months
28%
7 to 9 months
42%
Above 9 months
30%

Topics Covered on ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Dementia
Oxidative stress
Cognitive impairment
Physical performance
Alzheimer's disease
Exercise
Grip strength
Body composition
Genetic testing
Quality of life
Platelet activation
Magnetic resonance imaging
Activities of daily living
Cerebrospinal fluid
Body mass index
Confidence interval
Endothelial dysfunction
Moderate dementia
Episodic memory
Montreal Cognitive Assessment

ALZHEIMER DISEASE & ASSOCIATED DISORDERS Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year1987
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in ALZHEIMER DISEASE & ASSOCIATED DISORDERS ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Compare Similar Journals with ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Select Journals to Compare with ALZHEIMER DISEASE & ASSOCIATED DISORDERS
Total journals - 9
You can select up to 3 Journals at a time

Journal of Alzheimer's Disease

Publisher: IOS PRESS

Frontiers in Aging Neuroscience

Publisher: FRONTIERS MEDIA SA

International Journal of Geriatric Psychiatry

Publisher: WILEY

Alzheimer's Research and Therapy

Publisher: Springer Nature

Neurology

Publisher: LIPPINCOTT WILLIAMS & WILKINS

PLoS ONE

Publisher: PUBLIC LIBRARY SCIENCE

Frontiers in Neurology

Publisher: FRONTIERS MEDIA SA

Neurobiology of Aging

Publisher: ELSEVIER SCIENCE INC

Dementia and Geriatric Cognitive Disorders

Publisher: KARGER
0 Journals Selected to compare with
ALZHEIMER DISEASE & ASSOCIATED DISORDERS
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

Get detailed Journal comparison report on your email by signing up

Check if your research matches the topics covered in ALZHEIMER DISEASE & ASSOCIATED DISORDERS?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on ALZHEIMER DISEASE & ASSOCIATED DISORDERS

How long has ALZHEIMER DISEASE & ASSOCIATED DISORDERS been actively publishing? Faqs

ALZHEIMER DISEASE & ASSOCIATED DISORDERS has been in operation since 1987 till date.

What is the publishing frequency of ALZHEIMER DISEASE & ASSOCIATED DISORDERS? Faqs

ALZHEIMER DISEASE & ASSOCIATED DISORDERS published with a Quarterly frequency.

How many articles did ALZHEIMER DISEASE & ASSOCIATED DISORDERS publish last year? Faqs

In 2023, ALZHEIMER DISEASE & ASSOCIATED DISORDERS publsihed 59 articles.

What is the eISSN & pISSN for ALZHEIMER DISEASE & ASSOCIATED DISORDERS? Faqs

For ALZHEIMER DISEASE & ASSOCIATED DISORDERS, eISSN is 0893-0341 and pISSN is 0893-0341.

What is the SJR for ALZHEIMER DISEASE & ASSOCIATED DISORDERS? Faqs

SJR for ALZHEIMER DISEASE & ASSOCIATED DISORDERS is Q2.

Who is the publisher of ALZHEIMER DISEASE & ASSOCIATED DISORDERS? Faqs

LIPPINCOTT WILLIAMS & WILKINS is the publisher of ALZHEIMER DISEASE & ASSOCIATED DISORDERS.